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Chapter 11
Encapsulation of Human Articular Chondrocytes into 3D 
Hydrogel: Phenotype and Genotype Characterization
Rui C. Pereira, Chiara Gentili, Ranieri Cancedda, Helena S. Azevedo,  
and Rui L. Reis 
Abstract
This chapter is intended to provide a summary of the current materials used in cell encapsulation technol-
ogy as well as methods for evaluating the performance of cells encapsulated in a polymeric matrix. In 
particular, it describes the experimental procedure to prepare a hydrogel matrix based on natural poly-
mers for encapsulating and culturing human articular chondrocytes with the interest in cartilage regen-
eration. Protocols to evaluate the viability, proliferation, differentiation, and matrix production of 
embedded cells are also described and include standard protocols such as the MTT and [3H] Thymidine 
assays, reverse transcription polymerase chain reaction (RT-PCR) technique, histology, and immunohis-
tochemistry analysis. The assessment of cell distribution within the 3D hydrogel construct is also described 
using APoTome analysis.
Key words: Natural polymers, Hydrogels, Gelation, Chondrocyte encapsulation, Cell culture and 
survival within 3D matrix, Cell-based technology, Cartilage regeneration
Cell encapsulation technology holds promise in many areas of 
medicine and biotechnology. For example, some important 
applications are treatment of diabetes, production of biologically 
important chemicals, and controlled release of drugs. The hope 
that encapsulated cells might be used as a therapeutic strategy is 
increasingly being realized and is expected to have enormous 
potential in medicine in the near future. However, to be a viable 
complement to the current methods of cell transplantation ther-
apy, encapsulation technology has to fulfill the strict require-
ments applicable to these types of therapeutic strategies, such as 
1.  Introduction
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performance, biosafety, biocompatibility, stability, availability, 
purity, characterization, and cost (1). In a typical encapsulation 
process, cells are suspended in a liquid solution, which is then 
rapidly solidified or gelled to entrap cells in the matrix. It is 
widely understood that in order to encapsulate living cells within 
an artificial matrix, the encapsulating conditions must not dam-
age the living cells and the matrix material must be biocompati-
ble and at the same time provide a natural microenvironment for 
the cells to sustain their viability, function, and growth or dif-
ferentiation. Additionally the mechanical strength of the encap-
sulating matrix is critical, particularly when long-term 
implantation is envisaged. The mechanical strength is essential 
for maintaining the matrix integrity and to withstand manipula-
tions associated with in vitro culture, implantation, and in vivo 
existence. Moreover, it is essential that the matrix should have 
suitable diffusion properties to ensure sufficient access of nutri-
ents, for encapsulated cells to remain viable and functional, and 
the removal of secreted metabolic waste products. Thus, there is 
a need for relatively mild cell encapsulation methods, which 
offers control over properties of the encapsulating matrix.
An exciting approach for cell delivery is the use of materials 
that can undergo a gelation process that is cell-compatible and 
can be injected into the body (i.e., hydrogels). This approach 
enables the clinician to transplant the cell and polymer combina-
tion in a minimally invasive way (2). Hydrogels are appealing for 
cell delivery because they are highly hydrated three-dimensional 
networks of polymers that provide a place for cells to adhere, pro-
liferate, and differentiate and they can often be processed under 
relatively mild conditions. Gelation can occur through a change 
in temperature (thermoreversible gels), or via chemical crosslink-
ing, ionic crosslinking, or formation of an insoluble complex. 
Covalent crosslinking is a common method to precisely control 
the crosslinking density of hydrogels. However, the toxicity of 
cross-linking molecules must be considered. Many chemical 
crosslinking agents negatively impact cell viability and cause reac-
tions in vivo, precluding the use of most chemically crosslinked 
gels for encapsulation. Ionic crosslinking with multivalent coun-
terions is a simple way to form hydrogels. However, those ions 
could be exchanged with other ionic molecules in aqueous envi-
ronments, resulting in an uncontrolled deterioration of the origi-
nal properties of hydrogels.
Multicomponent blends of synthetic, semi-synthetic, and 
naturally occurring macromolecules have been explored for the 
encapsulation of a variety of mammalian cell types (3–5). 
Naturally-derived polymers are abundant, biodegradable, and 
usually undergo gelation under gentle conditions. In addition, 
they have shown low toxicity. Natural polyanions include 
several polysaccharides (e.g., alginate, carboxymethyl cellulose, 
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carrageenan, cellulose sulfate, gellan gum, gum arabic, heparin, 
hyaluronic acid, xanthan, dextran sulfate) and chitosan, the only 
naturally occurring polycation.
Although alginate-based materials are still receiving a great 
deal of attention, a wide variety of polyelectrolyte gels and com-
plexes have now been investigated for cell encapsulation. Alginate, 
a negatively-charged polysaccharide, can either be used alone, or 
in conjunction with positively-charged polylysine to form alg-
inate–polylysine polyelectrolyte complexes. Alginate itself may be 
ionically crosslinked by divalent cations such as calcium and bar-
ium. Although the encapsulating method based on ionic cross-
linking of alginate (a polyanion) with polylysine or polyomithine 
(polycation) offers relatively mild encapsulating conditions and 
quite stable matrices, their mechanical properties and long-term 
stability are poor. Moreover, these polymers when implanted 
in vivo, are susceptible to cellular overgrowth, which restricts the 
permeability of the matrices to nutrients, metabolites, and trans-
port proteins from the surroundings, leading to starvation and 
death of encapsulated cells.
Other encapsulation matrices have been tested and they were 
either not sufficiently mechanically stable or suffered from other 
surface or matrix related deficiencies such as shrinkage in either 
PBS or in culture media. In order to overcome these limitations, 
several approaches have been considered and tested, like crosslink-
ing, chemical adjustment of charge density, combination of low 
and high molecular weight polyelectrolytes, adjustment of osmotic 
pressure, polymer grafting, polymer blending, among others.
Currently, hydrogels are being used in an attempt to engineer 
a wide range of tissues, including cartilage, bone, muscle, fat, liver, 
and neurons. Hydrogels have a similar macromolecular structure 
to cartilage, which is a highly hydrated tissue composed of chon-
drocytes embedded in type II collagen and glycosaminoglycans. 
Thus, cartilage is an obvious tissue to engineer using hydrogel 
matrices. Numerous hydrogel systems embedded with chondro-
cytes have been developed and tested both in vitro and in vivo.
Carrageenans are high molecular weight sulfated polygalac-
tans derived from several species of red seaweeds (Rhodophyceae). 
The most common forms of carrageenan are l, k and i. Carrageenan 
has alternating disaccharide units composed of d-galactose-2-sul-
fate and d-galactose-2,6-disulfate, being the galactose residues 
joined by -1,3 and -1,4 linkages. Carrageenans resemble to some 
extent the naturally occurring glycosaminoglycans owing to their 
backbone composition of sulfated disaccharides. The different 
composition and conformation of carrageenans results in a wide 
range of rheological and functional properties. Carrageenans 
form thermoreversible gels. The polysaccharide is water soluble 
when heated and gels upon cooling the solution in presence of 
electrolytes (Ca2+ and K+). k-carrageenan gels in the presence 
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of K+ ions to form strong crisp gels, whereas i-carrageenan gels in 
the presence of Ca2+ ions to form elastic gels (6). Carrageenans 
have been used extensively in the food industry. In addition to 
incorporation in foods, carrageenan has been used as an ingredi-
ent in pharmaceuticals and personal care products, such as tooth-
paste and cosmetics (7).
The use of carrageenan has not been fully explored as poten-
tial biomaterial and we believe that the structural diversity of car-
rageenans can provide very interesting rheological and functional 
properties in cell encapsulation technology. Because of its wide-
spread use in food and pharmaceutical industry, purified carra-
geenan materials are readily available with reliable, predictable, 
and chemically defined composition.
The aim of the present chapter is to provide experimental 
procedures to prepare a hydrogel-based matrix for the encapsula-
tion of chondrocytes, and evaluate its potential as a cell-delivery 
carrier for cartilage regeneration strategies. We focus on methods 
for culturing and expanding human chondrocytes obtained from 
articular cartilage biopsies and evaluating the maintenance of cell 
viability and function within the 3D hydrogel matrix. 
Characterization methods to evaluate other properties of the 
hydrogel system, such as hydrogel strength and stability, gelation 
kinetics, and hydrogel permeability are also of central importance, 
but these topics will not be described in this chapter.
 1. Carrageenan polysaccharides (i- and k-carrageenans both 
from Fluka Biochemika, Denmark).
 2. Human fibrinogen and human thrombin (Baxter AG, Vienna, 
Austria) plus the syringe holder – Duploject. The syringe 
holder allows (with a single press) for an injectable hydrogel 
to be formed with an equal distribution of both 
components.
 3. High molecular weight hyaluronic acid from Bacillus subtilis 
(kindly provided by Prof. Hilborn, Uppsala University).
 4. Double distilled water, CaCl2 and KCl powders to trigger gel 
formation.
 1. Coon’s F-12 Modified Ham’s medium (Biochrom A.G. 
Berlin, Germany) supplemented with 10% fetal calf serum 
(FCS) (Invitrogen Life Technologies, Carlsbad, CA).
 2. Trypsin solution (0.25%) with ethylenediamine tetraacetic 
acid (EDTA) (1 mM) (Invitrogen Life Technologies, 
Carlsbad, CA).
2. Materials
2.1. Hydrogel
2.2. Cell Culture: 
Primary Culture  
of Human Articular 
Cartilage Biopsies
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 3. Collagenase I, collagenase II (both from Worthing 
Biochemical, Lakewood, NJ), hyaluronidase (Sigma, St. 
Louis, MO), and trypsin (Invitrogen Life Technologies, 
Carlsbad, CA). Store at −20°C.
 1. Coon’s F-12 Modified Ham’s medium supplemented with 
10% fetal calf serum.
 2. Serum free medium (8) freshly prepared twice a month in 
accordance with the composition listed in Table 1. Human 
recombinant growth factors (Austral Biologicals, San Ramon, 
CA, USA) and insulin (Sigma-Aldrich, Steinheim, Germany).
 3. Trypsin solution (0.25%) with ethylenediamine tetraacetic 
acid (EDTA) (1 mM).
 1. Agarose working solution 1% (w/v) in PBS (1×). Transfer 
this solution to a glass bottle and autoclave to ensure ade-
quate sterilization. Store at room temperature.
 2. Plastic ring containers (made, for example, of 2 mL plastic 
pipettes cut in equal parts, or pre-made plastic rings used in 
2.3. Cell Culture: 2D 
Monolayer Cell 
Expansion
2.4. Cell Culture:  
3D Cell Encapsulation 
and Culture Under 
Chondrogenic 
Differentiation
Table 1 
Serum free medium composition (adapted from 
Malpeli et al. (8))
Component (protein/growth factor) Final concentration
Apo-transferrin 25 mg/mL
Ascorbic acid 250 mM
Biotin 33 mM
Cholesterol 13 mM
Dexamethasone 10 nM
Epidermal growth factor 5 ng/mL
Fibroblast growth factor 2 5 ng/mL
Holo-transferrin 25 mg/mL
Human serum albumin 1% (w/v)
Insulin 10 mg/mL
Linoleic acid 4.5 mM
N-acetylcysteine 50 mM
Platelet derived growth factor 5 ng/mL
Sodium pantothenate 17 mM
Sodium selenite 30 nM
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cell biology laboratories to collect cell clones) to be used as a 
mold for the injectable hydrogel (to give form and shape). 
Choose an appropriate size to determine the volume of the 
hydrogel and sterilize by autoclaving.
 3. Chondrogenic medium (9): Coon’s F-12 Modified Ham’s 
medium supplemented with 6.25 mg/mL Bovine Insulin, 
6.25 mg/mL Human Apotransferrin, 1.25 mg/mL Linoleic 
Acid, 5.35 mg/mL Bovine Serum Albumin, 1 mM sodium 
pyruvate, 50 mg/mL Ascorbic acid, 10 ng/mL Transforming 
Growth Factor b-1 (TGF b-1), and 10−7 M dexamethasone.
 1. Thiazolyl Blue staining (MTT; Sigma-Aldrich) powder dis-
solved at concentration of 5 mg/mL in freshly prepared phos-
phate buffer solution (PBS) (1×). Store aliquots at −20°C.
 2. Spectrophotometer (Beckman Du® 640, USA).
 3. 1450 Microbeta – Liquid Scintillation & Luminescence 
Counter (Wallac, Triliux, USA).
 4. [Methyl-3H] Thymidine (Amerstam, GE Healthcare, UK) 
solution. Store at 2°C (see Note 1).
 5. EcoLite™ – Scintillation Liquid (JCN, Costa, CA, USA). 
Store at room temperature and protect from light.
 6. DNA buffer solution (Invitrogen, Carlsbad, CA, USA). Store 
at 4°C.
 7. Washing solutions, absolute ethanol, and PBS (1×). Store 
these solutions at room temperature.
 1. Axiovert 200M microscope equipped with the ApoTome 
module and the AxiocamHR camera (Carl Zeiss, Jena, 
Germany) as well as Axiovision Software (Carl Zeiss, Jena, 
Germany).
 2. Hoechst 33342 at final concentration of 5 mg/mL in PBS 
(1×). Store at 4°C and protect from light.
 1. Graded ethanol solutions (70, 90, 95, and 100%); xylene and 
wax.
 2. 4% Formaldehyde solution in PBS. Store aliquots at −20°C.
 3. Methanol/H2O2 solution: methanol/H2O2 (49:1, v/v). 
Store at 4°C.
 4. Sodium acetate solution: 50 mM Na Acetate, pH 5.0. Adjust 
the pH solution with HCl (0.05 M) or with NaOH 
(0.05 M).
 5. Peroxidase substratum solution: 3-amino-9-ethylcarbazole 
0.04% in dimethylformamide, 45 mM Na Acetate (pH 5), 
0.03% H2O2 (100:900:1). Store at room temperature and 
protect from light.
2.5. Viability  
and Proliferation of 
Encapsulated Cells
2.6. ApoTome Image 
Acquisition
2.7. Histology  
and Immunohisto- 
chemistry Analysis
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 6. Harris’s haematoxylin solution (Bio Optica, Milano, IT).
 7. Mounting medium: Gel mount (Biomeda Corp., Foster City, 
CA, USA).
 1. PCR supplies (microcentrifuge tubes, PCR tubes, PCR plates, 
pipette tips) and water (diethylpyrocarbonate (DEPC) treated 
water) free of DNAase/RNAase.
 2. Trizol Reagent (Invitrogen, Carlsbad, CA, USA). Store at 
4ºC.
 3. Homogenizer (Ultra Turrax® Model T25, IKA Labortechnik 
GMbH, Germany).
 4. 2-Isopropanol.
 5. Solution of chloroform/isoamyl alcohol (49:1) (v/v). Store 
at room temperature.
 6. 70% Ethanol solution. Store at −20°C.
 1. Weigh out 0.6 and 0.4 g of i- and k-carrageenans, respectively, 
and place them inside appropriate tubes to be autoclaved 
(120°C for 20 min) to ensure sterility. Sterilize double distilled 
water, glassware, and lab tools (e.g., two or three beakers, mag-
netic stirrers, and forceps) by autoclaving them prior to use.
 2. Under sterile conditions (laminar flow cabinet), heat 50 mL of 
double distilled water (covered with a cap to avoid evapora-
tion) up to 65°C and dissolve the carrageenan powder under 
constant stirring until forming a homogenous preparation.
 3. When the solution is clear, homogenous, and without bub-
bles, switch off the stirrer and the heater power. Leave it at 
room temperature. Transfer the polymeric solution to a 
50-mL tube. The solution is ready to be used. It can remain 
at room temperature from days to weeks until further use.
 1. Clean human articular cartilage biopsy samples from connec-
tive and muscular tissues and/or subchondral bone and cut 
them in small fragments (see Note 2).
 2. Wash articular cartilage fragments several times with freshly 
prepared PBS (1×) and centrifuge in PBS (1×) at 180 × g for 
5 min.
 3. Discard the supernatant and refill with the enzymatic cock-
tail solution made of: trypsin 0.25% (v/v), collagenase I 
(400 U/mL), collagenase II (1,000 U/mL), and hyaluronidase 
(1 mg/mL). Place in a thermostatic bath at 37°C for 30 min.
2.8. mRNA Extraction
3. Methods
3.1. Hydrogel 
Preparation
3.2. Human Articular 
Chondrocytes Primary 
Culture
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 4. Collect the supernatant and block the enzymatic activity with 
Coon’s modified ham’s medium with 10% fetal calf serum 
(FCS). Centrifuge for 10 min at 180 × g.
 5. Plate the cell suspension under anchorage-dependent condi-
tions: plastic Petri dishes coated with Coon’s modified ham’s 
medium with 10% of FCS.
 6. Repeat steps 3–5 until no biopsy material is available. Have in 
mind that this procedure can take from 2/3 h up to 1 entire 
day, depending on the amount of biopsy material. Therefore, 
prepare, at least 1 day before, chemicals and materials (ali-
quots of the different enzymatic solutions, solutions, several 
bistouries, and forceps) necessary to perform this procedure.
 7. Keep the cells in culture under conditions described in step 5 
for 3/4 days. Trypsinize cells and perform an initial count 
(counting is necessary to report cell duplication number rela-
tive to the starting number of primary cells). The next step is 
to re-plate the cells under serum-free medium conditions.
 1. Before starting the 2D monolayer expansion of human artic-
ular chondrocytes under serum-free medium conditions, it is 
important to be aware that all growth factors should be previ-
ously aliquoted and ready for use. The medium used during 
all the expansion period of a primary culture should be always 
from the same batch of aliquots. This is important for reduc-
ing variability between independent experiments.
 2. Enzymatically detach and count the cells (reported as step 7 
in Subheading 3.2). Use Coon’s modified Ham’s medium 
with 10% of FCS to block the activity of trypsin.
 3. Wash three times with PBS (1×) the Petri dish coated with 
Coon’s modified Ham’s medium (plus 10% FCS) to remove 
any residual traces of serum. Re-plate the cells at a density of 
4 × 104/cm2 using serum free medium prepared according to 
the Table 1. Change the medium three times a week.
 4. When cells have a sub-confluent distribution, repeat step 2 
using Coon’s modified Ham’s medium with 1% of FCS instead 
of 10% FCS. Repeat step 3 until the cell number reaches the 
number necessary to start the experiment.
 1. Prepare aliquots of fibrinogen at a final concentration of 
3,000 UIK/mL, as well as thrombin (500 IU/mL). Add 
hyaluronic acid powder to the latter solution to obtain a con-
centration of 0.75% w/v, and allow the polymer to dissolve 
overnight at 4°C under gentle shaking.
 2. At the end of in vitro cell expansion, detach enzymatically the 
cells and count them. Calculate the number of hydrogels to 
be prepared (with and without cells) based on the final number 
3.3. 2D Monolayer Cell 
Expansion
3.4. 3D Cell 
Encapsulation  
and Culture Under 
Chondrogenic 
Differentiation 
Conditions
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of cells available for encapsulation and the cell density within 
the 3D hydrogel.
 3. Prepare a medium that will trigger the gel formation of car-
rageenan solution. For that, dissolve CaCl2 (0.265 g/L) and 
KCl (0.4 g/L) in Coon’s modified Ham’s medium and render 
this solution sterile by syringe filtration (0.22-mm filter).
 4. Add fibrinogen solution 35% (v/v) to the carrageenan poly-
meric solution. Mix them well with a pipette avoiding the 
formation air bubbles (solution B). Make the cell suspension 
in the medium prepared in step 3 and add thrombin solution 
to a final concentration of 5.9% (v/v) (Solution A) (see Note 
3). The cell number depends on the final cell density within 
the hydrogel (i.e., 2 × 106 cells/mL). See Fig. 1.
 5. Load solution A and B in to two separate 1-mL syringes (see 
Fig. 1). Place them with care in the Duploject double syringe 
holder and set the connector at the syringe extremity end. 
Insert the needle and be ready to fill the plastic ring molds for 
giving shape and size to the injectable hydrogel.
 6. Mix well before starting the injection to avoid sinkage of cells 
to the bottom of the syringe by gravity. Inject the same volume 
Fig. 1. Schematic representation of the method to form the hydrogel. From the top left (following the arrows): human 
articular chondrocytes biopsy and successive digestions; Light microscopy image of primary monolayer culture in 
serum free medium during the 2D expansion period; biodegradable hydrogel system with the content composition in 
both syringes (a and b) and the macroscopic morphology of the formed gel. Reproduced with permission from Pereira 
et al. (14).
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of hydrogel into the rings within a 24 multi-well plate 
(previously coated with agar).
 7. Wait 5–10 min and turn the gels upside down to allow a bet-
ter cell distribution within the hydrogel (to avoid cells sinking 
to the bottom of the gel by gravity). Wait another 5–10 min. 
Meanwhile prepare the chondrogenic medium. Calculate the 
volume necessary to be prepared knowing that the total vol-
ume of the hydrogel must be covered with medium.
 8. Discard the plastic rings and add medium to each well. Place 
the 24 multi-well plate in to an incubator (37°C and 5% CO2). 
Change the chondrogenic medium three times a week.
It is necessary for each time point to evaluate the viability and 
proliferation rates of the human articular chondrocytes encapsu-
lated within the gel. Repeat the procedure described below: MTT 
assay corresponding to the viability analysis (10) and [methyl-3H] 
Thymidine (11) to proliferation.
 1. Prepare serum-free medium with MTT at a final concentra-
tion of 50 mL/mL. The final volume depends not only on the 
number of samples to be analyzed (remember to perform the 
analysis at least in triplicate) but also on the volume occupied 
by the construct. All individual samples must be completely 
immersed. The volume used for all the samples must be the 
same, even if their volume is different.
 2. At pre-determined time points, carefully remove the medium 
from the well in which the 3D construct was kept during the 
in vitro culture without damaging it.
 3. Refill the well with recently prepared medium described in 
step 1. Incubate (37°C and 5% CO2) for 2–3 h protected 
from light.
 4. Collect the medium and add 1 mL absolute ethanol. The 
hydrogel with encapsulated cells will form blue dots (the dots 
correspond to the cells). Break up the hydrogels by pipetting 
the construct up and down. The same number of movements 
should be applied to all the conditions.
 5. For each sample, collect 1 mL of liquid into separated tubes 
and measure the dye absorbance at 570 nm with background 
subtraction at 670 nm in a spectrophotometer.
 6. Repeat this procedure for remaining time points programmed 
for the experiment and at the end plot the absorbance values 
versus time.
 1. Prepare serum free medium with [methyl-3H] Thymidine at 
a final concentration 1 mCi/mL. Before handling radioactive 
material, ensure you are familiar with good radiation safety 
3.5. In Vitro Viability 
and Proliferation of 
Encapsulated Cells
3.5.1. MTT Assay ( Viability)
3.5.2. [Methyl-3H] 
Thymidine Assay 
(Proliferation)
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practice (see Note 1). Place all materials in contact with the 
radioactive material in a closed bag and place in a designated 
radioactive waste container for disposal.
 2. Remove the medium from the sample for analysis. Incubate 
the 3D constructs (37°C and 5% CO2) with the medium pre-
pared in step 1 for 16 h ensuring that the hydrogels are com-
pletely immersed in the medium.
 3. After the incubation period, collect the medium in a closed 
flask and place it in a container (designated for radioactive 
solutions). Wash the samples several times with PBS (1×) to 
remove residual [methyl-3H] Thymidine (i.e., not incorpo-
rated into cellular DNA) from the 3D hydrogels. Add these 
solutions to the flask containing [methyl-3H] Thymidine.
 4. Add 500 mL of DNA buffer solution to the 3D hydrogel and 
break up the hydrogel by pipetting up and down, according 
to the protocol used for the MTT assay (MTT, step 4). 
Recover the supernatant and store at −20°C.
 5. After collecting the samples for all the experimental time 
points, thaw the frozen samples and transfer 400 mL of the 
solubilized-cell solution into 4 mL scintillation vials and 
count. Specify a volume for each and add 2 mL of scintillation 
liquid. Transfer the solution to the Beta Counter containers 
and read. The samples must be performed in triplicate for 
each condition as a minimum. Plot the values versus time. 
Cell proliferation is evaluated by [methyl-3H] Thymidine 
incorporation, which correlates to cell number as a function 
of culture time.
This is an epifluorescent illumination technique (12, 13), which 
allows images to be obtained throughout most of the hydrogel 
without the need for any manipulation procedures, such as dehy-
dration for histology (which may introduce artifacts). This can be 
a powerful tool for in vitro cellular characterization (distribution 
and viability) of hydrogels.
 1. Carefully aspirate the medium from the well where the sam-
ples to be analyzed are located.
 2. Incubate (37°C and 5% CO2) the samples with a serum-free 
medium containing Hoechst 33342 at a final concentration 
of 5 mg/mL for 30 min (and protect from light).
 3. Transfer the hydrogel to a small Petri dish (3 mL) and start to 
acquire images by epifluorescent illumination using an 
Axiovert 200M microscope equipped with the ApoTome 
module. Set up the camera and select the correct filter for the 
required channel. Start the image acquisition stacking optical 
sections and subsequent 3D reconstruction using the 
Axiovision Software (see Fig. 2). During this procedure, 
3.6.  APoTome Analysis
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try not to overexpose the sample to the fluorescent light (to 
prevent photo bleaching). Afterwards, samples can be pro-
cessed for histology.
 1. Discard the medium, rinse the sample three times with PBS 
(1×) and transfer the sample to a test tube. Add 10 mL of 4% 
formaldehyde solution and incubate for 6 h under rotation 
conditions. Make sure that the tube is tightly closed to avoid 
possible leaks.
 2. Dehydrate the samples by immersing them in a graded series 
of ethanol solutions (70, 90, 95, and 100%) for 30 min each 
and xylene (10 min). Due to the high water content of the 
hydrogel, sample shrinkage is normally observed during 
dehydration (due to removal of the intrinsic water in the sam-
ple). Be careful not to lose any sample during the dehydration 
steps.
 3. Embed the hydrogels in paraffin. Perform a series of different 
melting points on the paraffin specifically at 45, 55, and 60°C 
(each one for 45 min). Perform the final paraffin inclusion 
and keep the sample at −20°C.
3.7. Histology  
and Immunohisto- 
chemistry Analysis
Fig. 2. Representative images of live human articular chondrocytes encapsulated within the hydrogel at 1 (a, c) and 3 
weeks (b, d) of culture after labeling of the cell nuclei with Hoechst and optical sectioning by structured epifluorescent 
illumination. An image projection along the X, Y, and Z axes (a, b), and their respective 3D reconstructed stacks (c, d). 
Reproduced with permission from Pereira et al. (14).
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 4. With the help of a microtome, cut sample sections with a 
thickness of between 4–6 mm. Dewax the sections repeating 
step 2 in reverse in order to perform any specific staining steps 
(e.g., Harris’s haematoxylin and Eosin, Toluidine Blue) or 
immunohistochemistry.
 1. After step 4, incubate the cut sections with methanol/H2O2 
(49/1) solution for 30 min to inhibit endogenous 
peroxidases.
 2. Discard the solution and incubate with hyaluronidase solu-
tion for 20–30 min. Wash several times with PBS (be careful 
to not detach the sample from the glass).
 3. To reduce non-specific binding, incubate with goat serum for 
1 h. Wash three times with PBS. Incubate with a specific pri-
mary antibody for 1 h at room temperature.
 4. Wash the sections three times with PBS and incubate with 
secondary biotinylated anti-mouse IgG and peroxidase-con-
jugated egg-white avidin. Wash the sections with PBS and 
add peroxidase substrate solution. Incubate at room tempera-
ture (protected from daylight) for a period of 15 min.
 5. Counterstain the sample with Harris’s haematoxylin. Mount 
the section with gel mount and observe by optical microscopy.
 1. Collect the medium from the wells and wash the 3D hydro-
gels several times with PBS.
 2. Aspirate the hydrogel carefully with the help of a pipette and 
place in a tube.
 3. Add 1 mL of Trizol and place immediately on ice.
 4. Homogenize the samples at 15,000 × g for 30 s, rinsing thor-
oughly the probe with DEPC water.
 5. Transfer 1 mL of sample to a 1.5-mL tube. Incubate at room 
temperature for 5 min. Add 200 mL of chloroform/isoamyl 
alcohol (49:1) and incubate the samples at room temperature 
for 4 min.
 6. Centrifuge at 12,000 × g for 10 min at 4°C.
 7. Collect the supernatant into a new 1.5-mL microcentrifuge 
tube. Be very careful not to disturb the lower part of the gra-
dient solution, to minimize possible protein contamination.
 8. Add an equal volume of 2-isopropanol per tube (1:1). Hand 
mix and incubate at room temperature for 10 min.
 9. Centrifuge at 12,000 × g for 10 min at 4°C. At this stage, a 
pellet will form in the bottom of the tube. Be aware of pos-
sible difficulties for visualizing the pellet due to its small size 
and irregular shape.
3.7.1. Immunohisto- 
chemistry
3.8. mRNA Extraction/
Isolation
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 10. Discard the liquid and add 1 mL of 70% ethanol. Centrifuge 
at 7,500 × g for 5 min at room temperature.
 11. Carefully remove the ethanol solution and dissolve the RNA 
pellet in water (50–100 mL RNAase-free water). The RNA of 
each sample is ready to be quantified and consequently used 
in a RT-PCR.
 1. [Methyl-3H) Thymidine is a radioactive reagent with an 
approximate 15 day decay period. When working with radio-
active chemicals, it is important to follow correct local and 
national safety guidelines. This will include the use of per-
sonal protective equipment (e.g., always work with gloves 
and use two pairs if possible) and the disposal of radioactive 
waste (radioactive liquids and other materials in contact with 
radioactive chemicals), which must be via designated contain-
ers for radioactive waste disposal.
 2. The importance of protocol design in yielding cells of adequate 
quantity and quality is paramount for the success of this tech-
nology. Therefore, several variables should be considered when 
performing any type of primary culture (i.e., the total final 
number of cells enzymatically obtained during the tissue diges-
tion and its biological quality). During the first step, it is very 
important to clean the biopsy sample from all adherent tissues 
(muscular, connective, and bone) to avoid possible contamina-
tion of cartilage cells. The biological quality of the primary 
culture will depend on the biological functionality of the tissue 
(cartilage in this case) and also on the degree of tissue purity.
 3. Having a homogeneous distribution of cells in the syringe 
before the injection of the hydrogel is extremely important. 
Be aware that by gravity cells in suspension will sink to the 
bottom of the gel. To avoid that, shake the syringe and try to 
keep it horizontal before injection. In this way, the cell distri-
bution within the hydrogel construct will be more uniform. 
Even knowing that this is an easy to handle injectable hydro-
gel, with in situ gelling properties, try to minimize any spill to 
avoid wasting cells and polymer solution.
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